(Total Views: 744)
Posted On: 03/13/2025 6:13:02 AM
Post# of 154875
From Fidelity:
McLean Capital Management resumes coverage for Cytodyn with NEUTRAL recommendation.
Investars Analyst Actions - public
3:12 PM ET Mar-11-2025
On March 11, 2025 McLean Capital Management resumed coverage for Cytodyn (CYDY.NaE) with a NEUTRAL recommendation.
McLean Capital Management resumes coverage for Cytodyn with NEUTRAL recommendation.
Investars Analyst Actions - public
3:12 PM ET Mar-11-2025
On March 11, 2025 McLean Capital Management resumed coverage for Cytodyn (CYDY.NaE) with a NEUTRAL recommendation.
(8)
(0)
